Cite

HARVARD Citation

    Kwok, W. et al. (2019). Efficacy of gefitinib at reduced dose in EGFR mutant non-small cell lung carcinoma. Anti-cancer drugs. 30 (10), p. . [Online]. 
  
Back to record